Outsourced Pharma White Papers

  1. Increasing Bioavailability With Amorphous Solid Dosage Formulations 11/10/2023

    Discover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.

  2. Microbial Challenge In-Use Studies 6/13/2024

    Learn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.

  3. Best Practices In Formulation And Lyophilization Development: Proteins, mAbs And ADCs 10/16/2024

    Discover how advancements in pharmaceutical freeze-drying are reshaping the process through better product understanding, precise process control, and innovations in equipment efficiency.

  4. Protein Stress Testing 4/28/2025

    Start your forced degradation studies early to uncover molecular risks, strengthen product stability, and ensure regulatory-ready development from the start.

  5. Biomanufacturing Readiness: A Validation Model For Multiproduct Facilities 6/12/2025

    Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.

  6. Insights And Effective Strategies For A Successful Technology Transfer 11/1/2024

    Discover key strategies for seamless pharmaceutical technology transfers that accelerate time to market, ensure product quality, and meet regulatory standards across the drug lifecycle.

  7. Future-Proofing Life Sciences Manufacturing: 2025 CDMO Trends 3/12/2025

    Review contract manufacturing's evolution, driven by technological advancements and regulatory changes, and how CMOs and CDMOs are navigating opportunities and challenges.

  8. Immunogenicity Risk Assessment In Drug Candidate Selection 1/22/2025

    Identify and address potential anti-drug immune responses early in development to streamline your drug’s path to clinical success—start smart and finish fast.

  9. Enhancing Safety And Efficacy Of mRNA-Based Therapeutics 2/11/2025

    Discover how Codex® HiCap RNA Polymerase optimizes mRNA yield while reducing dsRNA byproducts for safer, more effective therapeutics.

  10. Regulatory Considerations For Excipients Used In Lipid Nanoparticles 8/15/2024

    Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.